Clinical Study of Cord Blood-derived CAR NK Cells Targeting CD19/CD70 in Refractory/Relapsed B-cell Non-Hodgkin Lymphoma
Clinical trial NCT05667155 · UNKNOWN
Trial details
- NCT number
- NCT05667155
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-15
- Primary completion
- 2025-01-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.